Terbinafine in acrylic polymer for the treatment of onychomycosis in hemodialysis patients: a phase II clinical trial

Terbinafine in acrylic polymer for the treatment of onychomycosis in hemodialysis patients: a phase II clinical trial

IntroductionOnychomycosis is a nail infection caused by dermatophyte fungi, non-dermatophyte fungi, and yeast. Patients with chronic kidney disease on dialysis are part of the population that presents higher rates of this disease, mainly due to immunosuppression. Among patients with chronic kidney d...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jeanne Marie Queiroz Borges Bersano, Matheus Gobbo Cordeiro, Juliana Mozer Sciani, Iara Lúcia Tescarollo, Fernando Augusto Lima Marson
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-11-01
Series:	Frontiers in Medicine
Subjects:	antifungal clinical trial kidney dialysis microbiology nail plate debridement onychomycosis
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2024.1417985/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A case of refractory onychomycosis caused by Kloeckera apiculata: Successful treatment with itraconazole
by: Samantha S. Ehrlich-Fein, et al.
Published: (2024-12-01)

A Novel Machine Learning-based Diagnostic Algorithm for Detection of Onychomycosis through Nail Appearance
by: Serkan Düzayak, et al.
Published: (2023-08-01)

Onychomycosis Endonyx: A Systematic Review
by: Ernesto De-La-Rosa-Garibay, et al.
Published: (2025-04-01)

Dermoscopic (Onychoscopic) findings of various nail disorders among patients attending dermatology-teaching center in Sulaymaniyah city
by: Paiman Ahmed Kwekha Qadir, et al.
Published: (2023-06-01)

Global onychomycosis management and the challenges of antifungal stewardship
by: Aditya K. Gupta, et al.
Published: (2025-12-01)

Artificial Intelligence in Diagnosis and Management of Nail Disorders: A Narrative Review
by: Vishal Gaurav, et al.
Published: (2025-01-01)

Study of bases influence on the biopharmaceutical characteristics of the pastes for onychomycosis therapy
by: V. V. Luc, et al.
Published: (2018-08-01)

Onychomycosis among cancer patients undergoing chemotherapy in Tehran, Iran: a cross-sectional study
by: Fatemeh Fathi, et al.
Published: (2025-04-01)

The 2024 resurgence of Bordetella pertussis in Brazil and a decade-long epidemiological overview
by: Nathália Mariana Santos Sansone, et al.
Published: (2025-05-01)

Management of Alopecia and Onychomycosis in a Lupus Patient
by: Muzayyana Sakiinah, et al.
Published: (2024-12-01)

Antifungal Susceptibility Pattern of Non - Dermatophytic Fungi Causing Onychomycosis
by: Apurva Kaushal, et al.
Published: (2020-10-01)

Antifungal Susceptibility Pattern of Non - Dermatophytic Fungi Causing Onychomycosis
by: Apurva Kaushal, et al.
Published: (2020-10-01)

Black Superficial Onychomycosis Caused by Neoscytalidium Dimidiatum: A Clinical Overview
by: Hugo Monteiro Faver, et al.
Published: (2025-07-01)

A six-year retrospective study on the causative agents of onychomycosis in China: the emergence of dematiaceous fungi
by: Xin Ye, et al.
Published: (2025-05-01)

A case report of childhood onychomycosis caused by the rare yeast Kodamaea ohmeri
by: Thi Minh Chau Ngo, et al.
Published: (2025-03-01)

Diode Laser and Red-Laser Photodynamic Therapy with Toluidine Blue Gel for the Treatment of Onychomycosis: A Case Series
by: Sara García-Oreja, et al.
Published: (2025-02-01)

In vitro anti-onychomycosis and radical-scavenging activities of Pistacia lentiscus L.
by: Zoubir Belmokhtar, et al.
Published: (2025-07-01)

Retraction in the era of COVID-19 and its influence on evidence-based medicine: is science in jeopardy?
by: Matheus Negri Boschiero, et al.
Published: (2021-03-01)

Antimicrobial photodynamic therapy in onychomycosis management: A systematic review of clinical trials
by: Renata de Oliveira Alves, et al.
Published: (2025-08-01)

Onychomycosis with gray-green staining caused by Fusarium solani
by: Yoshihito Mima, et al.
Published: (2024-12-01)

Laser Treatment in Nail Disorders: A Comprehensive Review
by: Byalakere Shivanna Chandrashekar, et al.
Published: (2025-01-01)

EP-487 - EFICÁCIA DA DOXICICLINA COMO PROFILAXIA PÓS-EXPOSIÇÃO (DOXI-PEP) PARA PREVENIR INFECÇÕES SEXUALMENTE TRANSMISSÍVEIS (IST): UMA REVISÃO SISTEMÁTICA E META-ANÁLISE
by: Matheus Negri Boschiero, et al.
Published: (2024-10-01)

The Oropouche fever in Latin America: a hidden threat and a possible cause of microcephaly due to vertical transmission
by: Nathália Mariana Santos Sansone, et al.
Published: (2025-03-01)

Molecular identification and antifungal susceptibility profile of rare and emerging yeast species causing onychomycosis
by: Ahmad Jabrodini, et al.
Published: (2025-04-01)

Non-dermatophytic Onychomycosis: The Etiological Agents and their Antifungal Susceptibility Response to Plain Ciclopirox Versus Ciclopirox Coated on Silver Nanoparticles – An In vitro Study
by: Y. Valentina, et al.
Published: (2025-06-01)

Treatment of Onychomycosis and the Drug–Drug Interactions in Patients with Diabetes Mellitus and Diabetic Foot Syndrome: A Systematic Review
by: David Navarro-Pérez, et al.
Published: (2025-01-01)

Onikomikoz ve Tedavi Yaklaşımları
by: İhsan Çiftçi, et al.
Published: (2022-12-01)

Prevalence and Risk Factors Predicting Onychomycosis in Patients with and Without Diabetes Mellitus in Spain: A Cross-Sectional Study
by: David Navarro-Pérez, et al.
Published: (2024-11-01)

Analysis of Causative Factors and Potential Predictors of Onychomycosis: A Retrospective Single-Center Study in Poland
by: Andrzej K. Jaworek, et al.
Published: (2025-02-01)

Antifungal Activity of Tea Tree (<i>Melaleuca alternifolia</i> Cheel) Essential Oils against the Main Onychomycosis-Causing Dermatophytes
by: Esther Mingorance Álvarez, et al.
Published: (2024-09-01)

Retrospective study of onychomycosis patients treated with ciclopirox 8% HPCH and oral antifungals applying artificial intelligence to electronic health records
by: Gastón Roustan, et al.
Published: (2025-07-01)

A Two-step Protocol for Managing the Severe Consequences of Septic Arthritis in the Ankle
by: Chandan Narang, et al.
Published: (2023-12-01)

Use of a 3D Model with Reconstructed Human Epidermis Infected with Fungi and Covered with a Bovine Nail to Simulate Onychomycosis and to Evaluate the Effects of Antifungal Agents
by: Francesca Giulia Urso, et al.
Published: (2025-04-01)

Specific Primers and Nested PCR Find <i>Trichophyton rubrum</i> Missed by Culture of Ground Toenails from Onychomycosis in Podiatric Patients in Eastern Australia
by: Anjana C. Santosh, et al.
Published: (2025-07-01)

Apical root canal cleaning after preparation with endodontic instruments: a randomized trial in vivo analysis
by: Volmir João Fornari, et al.
Published: (2020-08-01)

Clinical and epidemiological study of onychomycosis among patients of the national institute of hygiene in rabat, Morocco (2016-2020)
by: Majda El Abbassi, et al.
Published: (2024-12-01)

Evaluation of the case fatality rate in 2 031 309 hospitalised Brazilian patients due to COVID-19: An observational study of the first 3 years of the pandemic in Brazil
by: Fernando Augusto Lima Marson, et al.
Published: (2025-05-01)

Chemical composition and antimycotic potential of basil, rosemary, clove and cinnamon essential oils against Trichophyton rubrum and Trichophyton mentagrophytes
by: Patrícia Abreu Pereira, et al.
Published: (2024-12-01)

An Assessment of the Antifungal Efficacy of a Novel Topical Onychomycosis Treatment Using Human Nail and Skin Infection Models
by: Anthony Brown, et al.
Published: (2025-04-01)

Central auditory system assessment in children and adolescents with cystic fibrosis: electrophysiology and central auditory processing
by: Paula Maria Martins-Duarte, et al.
Published: (2025-01-01)